Health and disease

Genetic evidence can provide information about susceptibility to some diseases and biological conditions.

The meaning of that evidence varies enormously.

A variant associated with a small statistical change in risk should not be interpreted in the same way as a rare pathogenic variant with a substantial biological effect.

Cardiovascular and metabolic health

Cardiovascular and metabolic conditions are particularly relevant to long-term health and longevity.

Research has identified genetic associations involving lipid metabolism, glucose regulation, blood pressure, inflammation and vascular biology.

For example, TCF7L2 is one of the most extensively studied genes associated with susceptibility to type 2 diabetes. The rs7903146 variant has been repeatedly associated with diabetes risk across large studies.

That association does not mean a carrier will develop diabetes.

Body composition, diet, physical activity, age, family history and many other factors remain important.

Thrombosis

Some genetic findings have a different clinical character.

Factor V Leiden, involving the F5 gene, is an established inherited thrombophilia associated with increased susceptibility to venous thromboembolism.

Even here, genotype does not determine that a clot will occur. Risk is affected by circumstances including age, surgery, immobility, pregnancy, medications and other genetic or acquired factors.

This demonstrates why genetic interpretation requires context rather than a simple list of "good" and "bad" variants.

MTHFR and the importance of restraint

Variants in MTHFR are widely discussed in consumer genetics.

Common MTHFR polymorphisms can influence folate metabolism and homocysteine biology, but claims made about them frequently extend beyond what clinical evidence supports.

Professional genetics guidance has cautioned against routine use of common MTHFR polymorphism testing for thrombophilia assessment.

Bioanalytix therefore distinguishes between the existence of a biological association and evidence that the association is clinically or financially actionable.

Cancer and neurological disease

Genetics also contributes to susceptibility for some cancers and neurological conditions.

The strength of those relationships ranges from high-impact pathogenic variants in particular genes to much smaller statistical associations distributed across the genome.

Bioanalytix should never collapse those very different forms of evidence into a single genetic "risk score" without appropriate interpretation.

From health evidence to planning

Health-related evidence may become financially relevant when exploring questions such as:

• healthcare and care reserves;
• potential changes in working life;
• insurance needs;
• retirement timing;
• liquidity requirements;
• longevity scenarios; and
• estate planning.

The connection is indirect.

A genetic observation informs evidence. Evidence informs scenarios. Scenarios help test a financial plan.

It does not turn a genetic variant into a financial instruction.